Agenda & Learning Objectives

 Participants in this program will be able to:
  • Discuss major changes to vaccincation guidelines and the impact on patients and practice
  • ​Explore dysplasia surveillance techniques in IBD
  • Examine sequencing of therapies with new molecules and combination biologics
Time
Title/Topic
Speakers/Facilitators
10:00 EST Meeting site open for sign in
Lobby open
Sponsor Exhibits open
Photo Booth open
 
11:00 EST  Patient Video & Opening Remarks 
Welcome, program objectives
CO-CHAIRS: 
Alain Bitton & John Marshall

(1) Vaccination Guidelines Session Moderator: John Marshall

11:15 EST 1.1 State-of-the-Art Plenary Presentation
Vaccination Guidelines Update
Objectives:
  • Provide update on New Vaccination Guidelines
  • Outline major changes
  • Discuss impact to IBD patients and practice
  • Brief COVID-19 Vaccine status
Jennifer Jones
11:35 EST 1.2 Expert Panel Discussion/Q&A

Objectives:
  • Moderator will receive questions from the audience and guide the Expert Panel to clarify key issues from the plenary presentation
  • Panel will respond to questions from the audience and discuss controversial management issues in IBD
MODERATOR:
John Marshall

 
PANEL:
Lisa Barrett

Eric Benchimol
Jennifer Jones
Cynthia Seo
w

11:55 EST

E-Mentoring in IBD Lit Quiz – Round One
MODERATOR:
Alain Bitton
12:00 EST Network Break (10 mins)   

(2) Dysplasia Surveillance in IBD Session Moderator: Alain Bitton

12:10 EST Rotation to Workshops  
12:15 EST 2.1 Case-based Workshop Breakout Session

Objectives:
  • Case to highlight learning objectives of the Plenary session
MODERATOR:
Alain Bitton

FACILITATORS:
Daniel Baumgart, Edmond-Jean Bernard,
Charles Bernstein, Brian Bressler,
Sharyle Fowler, Steven Gruchy,
Vivian Huang, Reena Khanna,
Dustin Loomes, Jeff McCurdy,
Remo Panaccione, Farhad Peerani,
Sophie Plamondon, Greg Rosenfeld, Hillary Steinhart, Chadwick Williams
13:00 EST Refreshment and Network Break (10 mins)  
13:10 EST
2.2 State-of-the-Art Plenary Presentation
Approaches to Dysplasia
Objectives:
  • Brief summary of the overall approach to surveillance
  • Current and novel techniques for endoscopic surveillance of dysplasia including chromoendoscopy
  • Endoscopic management of flat and polypoid dysplasia
Talat Bessissow
13:30 EST 2.3 Expert Panel Discussion/Q&A

Objectives:
  • Moderator will receive questions from the audience and guide the Expert Panel to clarify key issues from the plenary presentation
  • Panel will respond to questions from the audience and discuss controversial management issues in IBD
MODERATOR:
Alain Bitton

PANEL:
Talat Bessissow
Charles Bernstein
Karen Kroeker
Sanjay Murthy
13:50 EST E-Mentoring in IBD Lit Quiz – Round Two MODERATOR:
Alain Bitton
13:55 EST Virtual Sponsor Exhibits and Networking (30 mins)  

(3) Combination Therapy Session Moderator: John Marshall

14:25 EST Rotation to Workshops  
14:30 EST 3.1 Case-based Workshop Breakout Session

Objectives:
  • Case to highlight learning objectives of the Plenary session

FACILITATORS:
Daniel Baumgart, Edmond-Jean Bernard,
Charles Bernstein, Brian Bressler,
Sharyle Fowler, Steven Gruchy,
Vivian Huang, Reena Khanna,
Dustin Loomes, Jeff McCurdy,
Remo Panaccione, Farhad Peerani,
​Sophie Plamondon, Greg Rosenfeld, Hillary Steinhart, Chadwick Williams

15:15 EST Refreshment and Network Break (10 mins)  
15:25 EST 3.2 State-of-the-Art Plenary Presentation 
Advanced Therapies in IBD - Mix and Match?
Objectives:
  • Sequencing of therapies incorporating new molecules
  • Discuss new strategies in IBD with emphasis on combination biologics
Vipul Jairath
15:45 EST 3.3 Expert Panel Discussion/Q&A

Objectives:
  • Moderator will receive questions from the audience and guide the Expert Panel to clarify key issues from the plenary presentation
  • Panel will respond to questions from audience and discuss controversial management issues in IBD
MODERATOR:
John Marshall

PANEL:
 
Brian Feagan
Vipul Jairath
Remo Panaccione
Laura Targownik
16:05 EST Richard Fedorak Mentoring in IBD Award of Distinction TBA
16:20 EST Closing Remarks – Evaluation, Adjournment CO-CHAIRS: 
Alain Bitton &
John Marshall

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.